Adam Scott Levy

CIK 1693134 · CFO and Secretary · last filed 2026-02-20

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$1.15M

Companies

3

Total Filings

25

Lifetime Open-Market Net

-$9.01M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
MLYS CFO and Secretary 48,538 $23.62 $1.15M -$9.06M 16 2026-02-20
Fresh Tracks Therapeutics, Inc. (BBI) Delisted Chief Business Officer $2.35 $0 1 2020-03-18
Viridian Therapeutics, Inc.\DE (MGEN) Delisted Chief Business Officer 13,040 $51.5K 8 2019-02-08

Recent Filings · Page 3 of 3

25 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2018-02-13 Viridian Therapeutics, Inc.\DE (MGEN) Delisted Buy (P) +9,090 $50.0K EDGAR
2018-02-02 Viridian Therapeutics, Inc.\DE (MGEN) Delisted Grant (A) $0 EDGAR
2017-08-23 Viridian Therapeutics, Inc.\DE (MGEN) Delisted $0 EDGAR
2017-06-23 Viridian Therapeutics, Inc.\DE (MGEN) Delisted Buy (P) +200 $1.5K EDGAR
2017-02-16 Viridian Therapeutics, Inc.\DE (MGEN) Delisted Grant (A) $0 EDGAR
Showing 2125 of 25
Page 3 of 3
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.